Acadian Asset Management
ANIP icon

Acadian Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Acadian Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-388
Closed -$35K – 1953
2025
Q3 		$35K Buy
+388
New +$31.6K ﹤0.01% 1689
2021
Q3 		– Sell
-3,455
Closed -$121K – 1702
2021
Q2 		$121K Buy
+3,455
New +$118K ﹤0.01% 1587
2020
Q4 		– Sell
-7,171
Closed -$202K – 2192
2020
Q3 		$202K Sell
7,171
-50,791
-88% -$1.51M ﹤0.01% 1444
2020
Q2 		$1.88M Buy
57,962
+13,118
+29% +$470K 0.01% 758
2020
Q1 		$1.83M Buy
44,844
+16,984
+61% +$903K 0.01% 630
2019
Q4 		$1.72M Buy
27,860
+22,954
+468% +$1.52M 0.01% 736
2019
Q3 		$357K Buy
4,906
+604
+14% +$45.2K ﹤0.01% 1173
2019
Q2 		$355K Sell
4,302
-3,874
-47% -$276K ﹤0.01% 1092
2019
Q1 		$578K Buy
8,176
+3,054
+60% +$180K ﹤0.01% 1062
2018
Q4 		$231K Sell
5,122
-1,265
-20% -$66.3K ﹤0.01% 1078
2018
Q3 		$361K Buy
+6,387
New +$391K ﹤0.01% 955
2015
Q4 		– Sell
-79,611
Closed -$3.15M – 1393
2015
Q3 		$3.15M Buy
+79,611
New +$4.53M 0.02% 471
2015
Q2 		– Sell
-1,474
Closed -$92K – 1353
2015
Q1 		$92K Buy
1,474
+714
+94% +$43.4K ﹤0.01% 1032
2014
Q4 		$43K Buy
+760
New +$33.5K ﹤0.01% 1051

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management's ANIP Position: Q4 2025 in Review

Acadian Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2025, closing a stake of 388 shares — an estimated $35K sold.

Acadian Asset Management first reported a position in ANIP in Q4 2014 and held it in 14 quarters. The position peaked at $3.15M in Q3 2015. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • Acadian Asset Management reported no remaining ANI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Acadian Asset Management sold 388 ANI Pharmaceuticals shares in Q4 2025, an estimated $35K.
  • Acadian Asset Management first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 14 quarters.
  • Acadian Asset Management's ANI Pharmaceuticals position peaked at $3.15M in Q3 2015.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on Acadian Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.